S Y Tse
Vorstandsvorsitzender bei SINO BIOPHARMACEUTICAL LIMITED
Vermögen: 1 400 Mio $ am 30.04.2024
Aktive Positionen von S Y Tse
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SINO BIOPHARMACEUTICAL LIMITED | Direktor/Vorstandsmitglied | 23.10.2019 | - |
| Vorstandsvorsitzender | 28.07.2022 | - | |
Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd.
 Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd. Pharmaceuticals: MajorHealth Technology Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd. is an omni-channel smart retail pharmacy. It operates both offline and online retail pharmacies. It sells and delivers pharmaceutical products through its O2O and B2C platforms. It is also involved in the wholesale of pharmaceutical products to other industry customers. The company was founded by Can Li and Zhou Hua Chen on September 12, 2012 and is headquartered in Chengdu, China. | Direktor/Vorstandsmitglied | 10.11.2020 | - |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The private company was founded in 1969, and the CEO is Kang Xin Yu. | Vorsitzender | 30.07.2020 | - |
Karriereverlauf von S Y Tse
Ehemalige bekannte Positionen von S Y Tse
| Unternehmen | Position | Beginn | Ende |
|---|
Ausbildung von S Y Tse
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
| Schwarzman College | Graduate Degree |
Statistik
International
| China | 4 |
| Hong Kong | 2 |
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SINO BIOPHARMACEUTICAL LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd.
Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd. Pharmaceuticals: MajorHealth Technology Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd. is an omni-channel smart retail pharmacy. It operates both offline and online retail pharmacies. It sells and delivers pharmaceutical products through its O2O and B2C platforms. It is also involved in the wholesale of pharmaceutical products to other industry customers. The company was founded by Can Li and Zhou Hua Chen on September 12, 2012 and is headquartered in Chengdu, China. | Health Technology |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The private company was founded in 1969, and the CEO is Kang Xin Yu. | Health Technology |
